Clinical Trial Update: Cyproheptadine as an Appetite Stimulant [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for cyproheptadine as an appetite stimulant in Failure to Thrive. The study status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Failure to Thrive

Drugs mentioned

• Cyproheptadine (cyproheptadine)

Snippet

Sponsor: St. Justine's Hospital | Conditions: Failure to Thrive | Phase 4 | Status: UNKNOWN